This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Monsanto, Potash Downgraded By Lazard

NEW YORK ( TheStreet) -- Monsanto Co. (MON - Get Report) and Potash Corp. of Saskatchewan (POT - Get Report) were downgraded Wednesday by Lazard Capital Markets following a fiscal fourth quarter loss and weaker-than-expected 2013 outlook from Monsanto.

In lowering both Monsanto to "Neutral" from "Buy" analyst Edlain Rodriguez did not directly mention Monsanto's earnings results, released Wednesday morning. However, he appeared to allude to the pre-market selloff in the shares following Monsanto's announcement. Monsanto shares were down 2.31% to $88.47 20 minutes after the open Wednesday, while Potash shares were down 1.76% to $41.88.

"While we would have liked to keep recommending the stocks and say buy on weakness, we can't really point to any imminent improvement in fundamentals or upward earnings revisions that should lead to meaningful stock price appreciation," Rodriguez wrote. He argued fundamentals for potash--a key ingredient used in many fertilizers--"will remain challenged in the medium term as prices continue trending downward."

He added that prices would need to move lower to result in contract signings in India and China, "and with no prospect for higher prices, we believe downward earnings revisions will limit any upside."

-- Written by Dan Freed in New York.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MON $94.11 -0.17%
POT $17.58 -0.17%
AAPL $93.54 -1.40%
FB $117.13 0.34%
GOOG $694.22 0.46%


Chart of I:DJI
DOW 17,709.85 -120.91 -0.68%
S&P 500 2,064.99 -10.82 -0.52%
NASDAQ 4,777.2430 -28.0480 -0.58%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs